Small and micro-cap biotechnology enters May 2026 in a state of historic bifurcation. Large-cap pharmaceutical companies AbbVie facing the Humira cliff, Bristol-Myers Squibb managing Revlimid and Eliquis losses, Pfizer navigating post-COVID revenue normalisation are sitting on record cash balances and facing imminent patent cliffs …
Oil markets whipsawed on Tuesday after U.S. Defense Secretary Pete Hegseth confirmed that a ceasefire with Iran remains in place, sending West Texas Intermediate crude futures tumbling as much as 4% to below $102 per barrel. The selloff reversed gains logged in the previous …
Fiserv, the financial technology company that processes payments, manages merchant acquiring, and provides core banking infrastructure to thousands of financial institutions across the United States and internationally, fell 8.80% on Tuesday following a quarterly earnings report that failed to meet the market's expectations on …
Of all the large-cap earnings casualties on Tuesday, none was more dramatic than Shopify. A 15.62% single-session decline on volume nearly six times the daily average is not a market trimming positions after a mixed report — it is a wholesale repricing of risk, …
Revenue Growth Driven by IMCIVREE Commercial Expansion
Lumentum Holdings found itself in a paradox familiar to high-flying technology stocks on Tuesday evening: reporting one of the strongest quarters in its corporate history, only to watch its shares slide approximately 6% in after-hours trading. For a stock that had already surged 162% …
PayPal Holdings delivered first-quarter results that, on the surface, appeared to check the right boxes. Revenue came in ahead of consensus estimates, and earnings per share surpassed Wall Street's expectations, continuing a string of quarterly beats that CEO Alex Chriss has used to build …
Sandisk Corporation (SNDK) — +36.85%
Phase 3 Trial Results Strengthen Clinical Positioning in Cardiovascular Markets
RESOLVE Trial Data Signals Dose-Dependent Clinical Improvement